Clinical Trial Update: Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated intratumoral dendritic cell vaccination combined with local radiotherapy in patients with recurrent lymphoma. The study was withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Dendritic cell vaccine (intratumoral) (dendritic cell vaccine)

Snippet

Sponsor: Baylor Research Institute | Conditions: Lymphoma | Phase 1, Phase 2 | Status: WITHDRAWN